Jakobsen P H, McKay V, N'Jie R, Olaleye B O, D'Alessandro U, Zhang G H, Eggelte T A, Koch C, Greenwood B M
Department of Infectious Diseases, Centre for Medical Parasitology, Copenhagen University Hospital (Rigshopitalet), Denmark.
Infect Immun. 1998 Apr;66(4):1654-9. doi: 10.1128/IAI.66.4.1654-1659.1998.
Healthy Gambian children, children with clinical Plasmodium falciparum malaria, and children with asymptomatic P. falciparum infections were studied to investigate whether antitoxic activities may contribute to protection against malarial symptoms. Markers of inflammatory reactions, soluble tumor necrosis factor receptor I, and C-reactive protein were found in high concentrations in children with symptomatic P. falciparum malaria compared with levels in children with asymptomatic P. falciparum infections or in healthy children, indicating that inflammatory reactions are induced only in children with clinical symptoms. Concentrations of soluble tumor necrosis factor receptor I and C-reactive protein were associated with levels of parasitemia. We detected antitoxic activities in sera as measured by their capacity to block toxin-induced Limulus amoebocyte lysate (LAL) activation. Symptomatic children had decreased capacity to block induction of LAL activation by P. falciparum exoantigen. The decreased blocking activity was restored in the following dry season, when the children had no clinical malaria. Symptomatic children also had the highest immunoglobulin G (IgG) reactivities to conserved P. falciparum erythrocyte membrane protein 1 and "Pfalhesin" (band #3) peptides, indicating that such IgG antibodies are stimulated by acute disease but are lost rapidly after the disease episode. Half of the children with symptomatic infections had low levels of haptoglobin, suggesting that these children had chronic P. falciparum infections which may have caused symptoms previously. Only a few of the children with asymptomatic P. falciparum infections had high parasite counts, and antitoxic immunity in the absence of antiparasite immunity appears to be rare among children in this community.
对健康的冈比亚儿童、患有临床恶性疟原虫疟疾的儿童以及无症状恶性疟原虫感染的儿童进行了研究,以调查抗毒活性是否有助于预防疟疾症状。与无症状恶性疟原虫感染儿童或健康儿童相比,有症状的恶性疟原虫疟疾儿童体内炎症反应标志物、可溶性肿瘤坏死因子受体I和C反应蛋白的浓度较高,这表明炎症反应仅在有临床症状的儿童中诱发。可溶性肿瘤坏死因子受体I和C反应蛋白的浓度与疟原虫血症水平相关。我们通过血清阻断毒素诱导的鲎试剂(LAL)激活的能力来检测血清中的抗毒活性。有症状的儿童阻断恶性疟原虫外毒素诱导LAL激活的能力下降。在随后的旱季,当这些儿童没有临床疟疾时,这种下降的阻断活性得以恢复。有症状的儿童对保守的恶性疟原虫红细胞膜蛋白1和“Pfalhesin”(条带#3)肽也具有最高的免疫球蛋白G(IgG)反应性,这表明此类IgG抗体受急性疾病刺激,但在疾病发作后迅速消失。一半有症状感染的儿童触珠蛋白水平较低,这表明这些儿童患有慢性恶性疟原虫感染,可能之前就已出现症状。只有少数无症状恶性疟原虫感染的儿童寄生虫计数较高,在这个社区的儿童中,缺乏抗寄生虫免疫的抗毒免疫似乎很少见。